Healthcare Sector Stocks
The Healthcare sector has a total of 1063 stocks, with a combined market cap of $8.4 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 40.57.
Market Cap
8.4T
Revenue
4.52T
Profits
207.08B
PE Ratio
40.57
Profit Margin
4.59%
Dividend Yield
0.43%
1063 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 854.72B | 0.20% | 1,672,306 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 581.22B | - | 6,216,321 | 94.19B |
| 3 | ABBV | AbbVie Inc. | 375.69B | 0.38% | 4,477,831 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 318.03B | 0.35% | 1,239,156 | 58.74B |
| 5 | MRK | Merck & Co., Inc. | 303.00B | -0.41% | 8,665,772 | 65.01B |
| 6 | NVS | Novartis AG | 295.06B | 0.41% | 905,784 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 278.57B | 0.30% | 5,826,497 | 447.57B |
| 8 | AMGN | Amgen Inc. | 191.91B | 1.66% | 2,940,579 | 36.75B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 185.98B | -0.60% | 1,490,725 | 44.56B |
| 10 | ABT | Abbott Laboratories | 178.90B | -0.81% | 6,198,378 | 44.33B |
| 11 | GILD | Gilead Sciences, Inc. | 176.37B | 0.39% | 4,166,906 | 29.44B |
| 12 | NVO | Novo Nordisk A/S | 165.36B | -0.45% | 11,228,355 | 48.59B |
| 13 | ISRG | Intuitive Surgical, Inc. | 161.58B | -1.59% | 1,551,181 | 10.06B |
| 14 | PFE | Pfizer Inc. | 154.84B | -0.91% | 27,046,877 | 62.58B |
| 15 | DHR | Danaher Corporation | 136.58B | -1.63% | 2,902,614 | 24.57B |
| 16 | SYK | Stryker Corporation | 129.79B | -0.26% | 1,393,554 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 121.42B | 0.46% | 6,571,905 | 48.19B |
| 18 | GSK | GSK plc | 116.24B | 1.73% | 3,465,721 | 43.97B |
| 19 | SNY | Sanofi | 114.31B | -0.13% | 2,644,389 | 54.85B |
| 20 | VRTX | Vertex Pharmaceuticals Incorporated | 113.64B | 0.64% | 1,040,835 | 12.00B |
| 21 | HCA | HCA Healthcare, Inc. | 113.39B | 0.41% | 668,246 | 75.60B |
| 22 | MDT | Medtronic plc | 112.87B | -0.83% | 7,896,481 | 35.48B |
| 23 | MCK | McKesson Corporation | 106.98B | 0.26% | 593,213 | 397.96B |
| 24 | CVS | CVS Health Corporation | 101.04B | 0.06% | 5,160,682 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 91.07B | -2.05% | 12,700,981 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 78.80B | -0.99% | 596,760 | 14.34B |
| 27 | CI | The Cigna Group | 73.42B | 0.32% | 908,027 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 69.61B | -0.43% | 1,162,260 | 199.13B |
| 29 | COR | Cencora, Inc. | 62.73B | -0.76% | 1,197,002 | 325.78B |
| 30 | MDLN | Medline Inc. | 60.02B | 3.04% | 5,059,445 | 28.43B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 56.89B | -1.07% | 2,803,493 | 28.48B |
| 32 | CAH | Cardinal Health, Inc. | 50.78B | 0.31% | 1,051,318 | 244.67B |
| 33 | ZTS | Zoetis Inc. | 50.46B | 0.20% | 2,442,762 | 9.47B |
| 34 | ARGX | argenx SE | 49.22B | 1.97% | 298,709 | 4.24B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 46.56B | -1.20% | 448,094 | 4.30B |
| 36 | EW | Edwards Lifesciences Corporation | 45.63B | -3.13% | 5,468,794 | 6.07B |
| 37 | BDX | Becton, Dickinson and Company | 44.27B | -1.04% | 2,709,768 | 21.92B |
| 38 | HLN | Haleon plc | 43.61B | 0.40% | 4,980,331 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.61B | -1.82% | 1,119,212 | 3.71B |
| 40 | ALC | Alcon Inc. | 37.63B | 0.12% | 1,303,868 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 36.05B | 1.44% | 3,424,713 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 34.75B | 0.39% | 142,251 | 5.34B |
| 43 | INSM | Insmed Incorporated | 34.45B | -0.37% | 1,564,023 | 606.42M |
| 44 | GEHC | GE HealthCare Technologies Inc. | 33.27B | -1.14% | 3,579,522 | 20.63B |
| 45 | RMD | ResMed Inc. | 33.07B | -1.18% | 1,141,023 | 5.40B |
| 46 | A | Agilent Technologies, Inc. | 32.61B | -1.31% | 1,218,694 | 7.07B |
| 47 | WAT | Waters Corporation | 31.16B | -0.28% | 883,434 | 3.17B |
| 48 | NTRA | Natera, Inc. | 28.77B | -3.71% | 1,490,764 | 2.31B |
| 49 | IQV | IQVIA Holdings Inc. | 28.37B | -2.06% | 1,912,643 | 16.31B |
| 50 | RPRX | Royalty Pharma plc | 27.86B | 0.84% | 2,220,743 | 2.38B |
| 51 | MTD | Mettler-Toledo International Inc. | 27.03B | 0.93% | 158,704 | 4.03B |
| 52 | PHG | Koninklijke Philips N.V. | 26.70B | 0.29% | 1,101,078 | 20.94B |
| 53 | BIIB | Biogen Inc. | 25.99B | -1.55% | 1,266,354 | 9.89B |
| 54 | VEEV | Veeva Systems Inc. | 25.66B | -5.70% | 4,308,602 | 3.20B |
| 55 | DXCM | DexCom, Inc. | 25.28B | -0.18% | 3,762,229 | 4.66B |
| 56 | UTHR | United Therapeutics Corporation | 25.19B | -1.19% | 415,385 | 3.18B |
| 57 | HUM | Humana Inc. | 23.69B | -0.54% | 1,319,945 | 129.66B |
| 58 | BNTX | BioNTech SE | 23.26B | -0.11% | 761,689 | 3.37B |
| 59 | LH | Labcorp Holdings Inc. | 22.52B | -0.53% | 454,265 | 13.95B |
| 60 | STE | STERIS plc | 21.94B | -0.57% | 517,074 | 5.83B |
| 61 | DGX | Quest Diagnostics Incorporated | 21.90B | -0.50% | 718,335 | 11.04B |
| 62 | ROIV | Roivant Sciences Ltd. | 20.38B | 1.10% | 4,076,184 | 13.31M |
| 63 | MRNA | Moderna, Inc. | 20.34B | -1.57% | 4,436,033 | 1.94B |
| 64 | INCY | Incyte Corporation | 19.30B | 1.12% | 1,089,394 | 5.14B |
| 65 | RVMD | Revolution Medicines, Inc. | 19.07B | -0.55% | 1,283,270 | - |
| 66 | ILMN | Illumina, Inc. | 18.91B | -3.38% | 2,307,092 | 4.34B |
| 67 | WST | West Pharmaceutical Services, Inc. | 18.62B | -2.78% | 785,136 | 3.07B |
| 68 | CNC | Centene Corporation | 18.47B | 0.72% | 3,663,567 | 176.15B |
| 69 | ZBH | Zimmer Biomet Holdings, Inc. | 18.01B | 0.02% | 1,712,135 | 8.23B |
| 70 | THC | Tenet Healthcare Corporation | 17.56B | 1.27% | 763,737 | 21.31B |
| 71 | GMAB | Genmab A/S | 17.32B | -0.42% | 2,026,564 | 3.72B |
| 72 | VTRS | Viatris Inc. | 15.85B | 0.29% | 5,738,302 | 14.30B |
| 73 | SMMT | Summit Therapeutics Inc. | 14.97B | 2.66% | 1,868,283 | - |
| 74 | ASND | Ascendis Pharma A/S | 14.93B | 3.65% | 882,426 | 845.52M |
| 75 | BBIO | BridgeBio Pharma, Inc. | 14.64B | 1.86% | 2,410,852 | 502.08M |
| 76 | MEDP | Medpace Holdings, Inc. | 14.32B | -3.68% | 364,439 | 2.53B |
| 77 | SNN | Smith & Nephew plc | 14.07B | 0.30% | 848,806 | 6.16B |
| 78 | COO | The Cooper Companies, Inc. | 13.94B | -0.38% | 1,277,144 | 4.15B |
| 79 | RGC | Regencell Bioscience Holdings Limited | 13.93B | -2.46% | 78,695 | - |
| 80 | PODD | Insulet Corporation | 13.81B | -2.01% | 813,801 | 2.71B |
| 81 | NBIX | Neurocrine Biosciences, Inc. | 13.21B | -1.13% | 820,306 | 2.86B |
| 82 | PEN | Penumbra, Inc. | 12.96B | -0.47% | 502,918 | 1.40B |
| 83 | FMS | Fresenius Medical Care AG | 12.66B | 0.77% | 487,460 | 23.05B |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 12.63B | 1.93% | 1,200,959 | 943.71M |
| 85 | ALGN | Align Technology, Inc. | 12.50B | -1.30% | 970,059 | 4.03B |
| 86 | GMED | Globus Medical, Inc. | 12.36B | -0.61% | 809,740 | 2.94B |
| 87 | JAZZ | Jazz Pharmaceuticals plc | 12.20B | 1.13% | 946,687 | 4.27B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.03B | 0.88% | 268,890 | 958.40M |
| 89 | EXEL | Exelixis, Inc. | 11.79B | 2.74% | 1,813,072 | 2.32B |
| 90 | ENSG | The Ensign Group, Inc. | 11.77B | -1.58% | 396,397 | 5.06B |
| 91 | ELAN | Elanco Animal Health Incorporated | 11.66B | -0.59% | 4,504,665 | 4.72B |
| 92 | UHS | Universal Health Services, Inc. | 11.48B | 0.60% | 331,385 | 17.36B |
| 93 | SOLV | Solventum Corporation | 11.48B | 1.43% | 1,782,002 | 8.33B |
| 94 | GH | Guardant Health, Inc. | 11.43B | -6.11% | 1,815,323 | 982.02M |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 10.92B | 0.15% | 2,316,494 | 3.85B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 10.83B | -1.57% | 1,048,299 | 3.22B |
| 97 | EHC | Encompass Health Corporation | 10.77B | 1.42% | 953,110 | 5.94B |
| 98 | RVTY | Revvity, Inc. | 10.11B | 0.07% | 1,095,684 | 2.86B |
| 99 | DVA | DaVita Inc. | 10.06B | 1.51% | 556,082 | 13.64B |
| 100 | ABVX | ABIVAX Société Anonyme | 9.77B | 5.66% | 1,058,866 | 5.37M |
| 101 | BTSG | BrightSpring Health Services, Inc. | 9.37B | -0.84% | 1,397,391 | 12.91B |
| 102 | MASI | Masimo Corporation | 9.31B | 0.02% | 627,537 | 1.53B |
| 103 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.27B | 2.91% | 1,422,970 | 1.09B |
| 104 | AXSM | Axsome Therapeutics, Inc. | 9.15B | 3.30% | 986,016 | 638.50M |
| 105 | BAX | Baxter International Inc. | 8.93B | 0.35% | 5,487,786 | 11.24B |
| 106 | PRAX | Praxis Precision Medicines, Inc. | 8.92B | 0.01% | 293,426 | 7.46M |
| 107 | PCVX | Vaxcyte, Inc. | 8.88B | 2.65% | 1,213,132 | - |
| 108 | TECH | Bio-Techne Corporation | 8.69B | 0.65% | 2,239,502 | 1.22B |
| 109 | HSIC | Henry Schein, Inc. | 8.68B | 0.12% | 698,953 | 13.18B |
| 110 | CRL | Charles River Laboratories International, Inc. | 8.64B | 0.27% | 839,126 | 4.02B |
| 111 | QGEN | Qiagen N.V. | 8.48B | -0.63% | 1,113,974 | 2.09B |
| 112 | ATR | AptarGroup, Inc. | 8.38B | -0.47% | 424,118 | 3.78B |
| 113 | NUVL | Nuvalent, Inc. | 8.22B | -0.43% | 396,734 | - |
| 114 | ICLR | ICON Public Limited Company | 8.15B | 0.15% | 692,962 | 8.10B |
| 115 | CYTK | Cytokinetics, Incorporated | 7.96B | -1.79% | 1,364,666 | 88.04M |
| 116 | HALO | Halozyme Therapeutics, Inc. | 7.95B | 2.52% | 1,259,493 | 1.40B |
| 117 | TEM | Tempus AI, Inc. | 7.89B | -7.03% | 5,785,228 | 1.27B |
| 118 | IBRX | ImmunityBio, Inc. | 7.72B | 7.16% | 21,609,774 | 113.29M |
| 119 | KRYS | Krystal Biotech, Inc. | 7.60B | -2.23% | 228,211 | 389.13M |
| 120 | MOH | Molina Healthcare, Inc. | 7.56B | -1.69% | 697,844 | 43.56B |
| 121 | BIO | Bio-Rad Laboratories, Inc. | 7.49B | -1.30% | 293,764 | 2.58B |
| 122 | KYMR | Kymera Therapeutics, Inc. | 7.13B | 0.25% | 510,044 | 39.21M |
| 123 | BLTE | Belite Bio, Inc | 7.13B | 1.37% | 162,751 | - |
| 124 | HQY | HealthEquity, Inc. | 7.11B | 2.75% | 1,122,074 | 1.31B |
| 125 | GKOS | Glaukos Corporation | 6.93B | 0.70% | 536,001 | 507.44M |
| 126 | RGEN | Repligen Corporation | 6.76B | 0.01% | 609,718 | 738.26M |
| 127 | ACLX | Arcellx, Inc. | 6.74B | 0.01% | 469,608 | 22.29M |
| 128 | PTGX | Protagonist Therapeutics, Inc. | 6.64B | 1.95% | 699,455 | 46.02M |
| 129 | GRFS | Grifols, S.A. | 6.47B | -4.05% | 973,483 | 8.83B |
| 130 | APGE | Apogee Therapeutics, Inc. | 6.39B | 4.09% | 770,217 | - |
| 131 | CNTA | Centessa Pharmaceuticals plc | 6.15B | 0.58% | 1,964,725 | 15.00M |
| 132 | TERN | Terns Pharmaceuticals, Inc. | 6.07B | -0.19% | 11,827,470 | - |
| 133 | CELC | Celcuity Inc. | 6.02B | 6.58% | 1,119,844 | - |
| 134 | COGT | Cogent Biosciences, Inc. | 6.02B | 1.08% | 2,473,044 | - |
| 135 | MIRM | Mirum Pharmaceuticals, Inc. | 5.97B | 1.02% | 439,180 | 521.31M |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.88B | 0.76% | 604,250 | 189.76M |
| 137 | PTCT | PTC Therapeutics, Inc. | 5.86B | -0.58% | 1,041,166 | 1.73B |
| 138 | BLCO | Bausch + Lomb Corporation | 5.84B | -0.36% | 223,327 | 5.10B |
| 139 | ALKS | Alkermes plc | 5.81B | 0.43% | 2,049,838 | 1.48B |
| 140 | CGON | CG Oncology, Inc. | 5.79B | -0.45% | 897,057 | 4.04M |
| 141 | BRKR | Bruker Corporation | 5.78B | -0.71% | 1,485,128 | 3.44B |
| 142 | PACS | PACS Group, Inc. | 5.65B | 1.67% | 637,411 | 5.29B |
| 143 | SRRK | Scholar Rock Holding Corporation | 5.65B | -1.60% | 1,317,524 | - |
| 144 | XENE | Xenon Pharmaceuticals Inc. | 5.59B | 1.82% | 764,411 | 7.50M |
| 145 | CAI | Caris Life Sciences, Inc. | 5.43B | -1.59% | 2,099,799 | 812.03M |
| 146 | ERAS | Erasca, Inc. | 5.40B | 2.48% | 3,430,136 | - |
| 147 | CHE | Chemed Corporation | 5.38B | -1.11% | 205,172 | 2.53B |
| 148 | AVTR | Avantor, Inc. | 5.35B | -1.00% | 8,791,672 | 6.55B |
| 149 | TFX | Teleflex Incorporated | 5.32B | 1.04% | 981,660 | 1.99B |
| 150 | LNTH | Lantheus Holdings, Inc. | 5.29B | 1.75% | 692,940 | 1.54B |
| 151 | IMVT | Immunovant, Inc. | 5.22B | 3.72% | 1,847,679 | - |
| 152 | APLS | Apellis Pharmaceuticals, Inc. | 5.20B | -0.10% | 7,061,683 | 1.00B |
| 153 | TGTX | TG Therapeutics, Inc. | 5.11B | 1.23% | 1,527,253 | 616.29M |
| 154 | CRSP | CRISPR Therapeutics AG | 4.96B | -0.08% | 1,100,040 | 3.51M |
| 155 | DNTH | Dianthus Therapeutics, Inc. | 4.85B | 4.78% | 652,717 | 2.04M |
| 156 | OPCH | Option Care Health, Inc. | 4.61B | 1.06% | 2,077,357 | 5.65B |
| 157 | FOLD | Amicus Therapeutics, Inc. | 4.54B | 0.07% | 2,735,678 | 634.21M |
| 158 | HIMS | Hims & Hers Health, Inc. | 4.50B | 1.86% | 14,699,865 | 2.35B |
| 159 | CORT | Corcept Therapeutics Incorporated | 4.49B | 0.91% | 925,447 | 761.41M |
| 160 | NVST | Envista Holdings Corporation | 4.37B | 0.04% | 2,041,022 | 2.72B |
| 161 | ALHC | Alignment Healthcare, Inc. | 4.37B | 0.33% | 2,003,391 | 3.95B |
| 162 | RDNT | RadNet, Inc. | 4.35B | 0.29% | 620,452 | 2.04B |
| 163 | SHC | Sotera Health Company | 4.35B | 0.26% | 1,858,737 | 1.16B |
| 164 | OSCR | Oscar Health, Inc. | 4.32B | -0.68% | 6,086,610 | 11.70B |
| 165 | WAY | Waystar Holding Corp. | 4.18B | -3.71% | 2,479,659 | 1.10B |
| 166 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.15B | -0.83% | 857,758 | 7.70M |
| 167 | LGND | Ligand Pharmaceuticals Incorporated | 4.10B | -1.18% | 258,091 | 268.09M |
| 168 | AMRX | Amneal Pharmaceuticals, Inc. | 4.08B | 0.71% | 1,033,868 | 3.02B |
| 169 | MMSI | Merit Medical Systems, Inc. | 4.08B | -0.85% | 618,623 | 1.52B |
| 170 | SYRE | Spyre Therapeutics, Inc. | 4.07B | -0.40% | 587,537 | - |
| 171 | VKTX | Viking Therapeutics, Inc. | 4.05B | 3.80% | 2,064,001 | - |
| 172 | NAMS | NewAmsterdam Pharma Company N.V. | 4.03B | 3.12% | 426,333 | 22.50M |
| 173 | DOCS | Doximity, Inc. | 3.91B | -3.20% | 5,091,951 | 637.78M |
| 174 | GPCR | Structure Therapeutics Inc. | 3.91B | 3.82% | 589,514 | - |
| 175 | MMED | Minimed Group, Inc. | 3.88B | 1.77% | 1,265,946 | 2.89B |
| 176 | ACAD | ACADIA Pharmaceuticals Inc. | 3.85B | 0.04% | 1,229,431 | 1.07B |
| 177 | IRTC | iRhythm Holdings, Inc. | 3.82B | -1.93% | 348,267 | 747.14M |
| 178 | BLLN | BillionToOne, Inc. | 3.79B | -10.31% | 446,591 | 305.11M |
| 179 | STVN | Stevanato Group S.p.A. | 3.75B | -0.29% | 304,076 | 1.39B |
| 180 | TMDX | TransMedics Group, Inc. | 3.75B | -0.15% | 537,347 | 605.49M |
| 181 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.62B | 0.64% | 666,517 | 677.56M |
| 182 | EWTX | Edgewise Therapeutics, Inc. | 3.60B | 1.45% | 575,055 | - |
| 183 | LQDA | Liquidia Corporation | 3.55B | 5.58% | 1,209,427 | 158.32M |
| 184 | LIVN | LivaNova PLC | 3.47B | -2.00% | 641,583 | 1.39B |
| 185 | LEGN | Legend Biotech Corporation | 3.37B | -0.55% | 1,551,166 | 1.03B |
| 186 | BKD | Brookdale Senior Living Inc. | 3.27B | -2.48% | 4,389,295 | 3.05B |
| 187 | TLX | Telix Pharmaceuticals Limited | 3.27B | 0.20% | 135,080 | 803.79M |
| 188 | DYN | Dyne Therapeutics, Inc. | 3.19B | 5.33% | 2,004,221 | - |
| 189 | ORKA | Oruka Therapeutics, Inc. | 3.15B | 2.56% | 837,134 | - |
| 190 | ICUI | ICU Medical, Inc. | 3.14B | 1.54% | 224,977 | 2.23B |
| 191 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.13B | 1.15% | 1,534,417 | 588.99M |
| 192 | TARS | Tarsus Pharmaceuticals, Inc. | 3.08B | 0.74% | 234,916 | 451.36M |
| 193 | DNLI | Denali Therapeutics Inc. | 3.06B | -1.68% | 1,435,412 | - |
| 194 | ARQT | Arcutis Biotherapeutics, Inc. | 3.05B | -0.16% | 837,936 | 376.07M |
| 195 | TWST | Twist Bioscience Corporation | 2.99B | -4.55% | 736,421 | 391.56M |
| 196 | SUPN | Supernus Pharmaceuticals, Inc. | 2.97B | -0.21% | 498,756 | 718.95M |
| 197 | TNGX | Tango Therapeutics, Inc. | 2.95B | 3.19% | 2,907,790 | 62.38M |
| 198 | ITGR | Integer Holdings Corporation | 2.95B | -0.93% | 278,092 | 1.85B |
| 199 | TXG | 10x Genomics, Inc. | 2.94B | -0.09% | 2,118,555 | 642.82M |
| 200 | VERA | Vera Therapeutics, Inc. | 2.92B | 1.49% | 1,643,316 | - |
| 201 | RCUS | Arcus Biosciences, Inc. | 2.92B | 2.78% | 565,759 | 247.00M |
| 202 | ALMS | Alumis Inc. | 2.92B | 1.01% | 975,142 | 24.05M |
| 203 | TVTX | Travere Therapeutics, Inc. | 2.90B | -0.76% | 1,851,690 | 490.73M |
| 204 | PRVA | Privia Health Group, Inc. | 2.85B | - | 1,141,719 | 2.12B |
| 205 | CON | Concentra Group Holdings Parent, Inc. | 2.85B | 1.28% | 572,733 | 2.16B |
| 206 | HNGE | Hinge Health, Inc. | 2.83B | -6.03% | 810,851 | 587.86M |
| 207 | NHC | National HealthCare Corporation | 2.76B | 2.58% | 164,242 | 1.52B |
| 208 | ELVN | Enliven Therapeutics, Inc. | 2.73B | 6.20% | 2,270,262 | - |
| 209 | IDYA | IDEAYA Biosciences, Inc. | 2.72B | 0.13% | 1,416,058 | 218.71M |
| 210 | SLNO | Soleno Therapeutics, Inc. | 2.72B | -0.17% | 6,384,292 | 190.41M |
| 211 | HAE | Haemonetics Corporation | 2.71B | -1.86% | 559,096 | 1.32B |
| 212 | PBH | Prestige Consumer Healthcare Inc. | 2.69B | 2.16% | 586,325 | 1.10B |
| 213 | RLAY | Relay Therapeutics, Inc. | 2.68B | 3.38% | 3,079,776 | 15.36M |
| 214 | CLDX | Celldex Therapeutics, Inc. | 2.64B | 3.73% | 815,378 | 1.55M |
| 215 | BEAM | Beam Therapeutics Inc. | 2.61B | 3.50% | 2,011,238 | 139.74M |
| 216 | KOD | Kodiak Sciences Inc. | 2.61B | 1.34% | 628,867 | - |
| 217 | GRDN | Guardian Pharmacy Services, Inc. | 2.57B | 1.55% | 467,982 | 1.45B |
| 218 | IRON | Disc Medicine, Inc. | 2.57B | 1.55% | 321,531 | - |
| 219 | LMAT | LeMaitre Vascular, Inc. | 2.57B | 0.27% | 125,514 | 249.60M |
| 220 | WRBY | Warby Parker Inc. | 2.56B | -1.69% | 1,865,738 | 871.91M |
| 221 | IMNM | Immunome, Inc. | 2.54B | 3.50% | 888,286 | 6.94M |
| 222 | LFST | LifeStance Health Group, Inc. | 2.53B | -0.76% | 1,779,452 | 1.42B |
| 223 | ACHC | Acadia Healthcare Company, Inc. | 2.50B | 3.38% | 3,888,011 | 3.31B |
| 224 | VCYT | Veracyte, Inc. | 2.49B | -4.04% | 510,405 | 517.15M |
| 225 | HCM | HUTCHMED (China) Limited | 2.48B | 1.20% | 28,407 | 548.51M |
| 226 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.48B | 1.12% | 4,608,553 | 874.84M |
| 227 | PAHC | Phibro Animal Health Corporation | 2.40B | 0.73% | 216,202 | 1.46B |
| 228 | ADMA | ADMA Biologics, Inc. | 2.37B | 1.12% | 4,797,572 | 510.17M |
| 229 | XRAY | DENTSPLY SIRONA Inc. | 2.37B | -1.08% | 2,992,371 | 3.68B |
| 230 | RARE | Ultragenyx Pharmaceutical Inc. | 2.35B | 3.28% | 1,968,312 | 673.00M |
| 231 | ZLAB | Zai Lab Limited | 2.34B | -3.04% | 1,035,946 | 460.16M |
| 232 | SRPT | Sarepta Therapeutics, Inc. | 2.33B | 1.51% | 1,884,660 | 2.20B |
| 233 | HTFL | HeartFlow, Inc. | 2.32B | - | 1,048,863 | 176.03M |
| 234 | AAPG | Ascentage Pharma Group International | 2.32B | -2.56% | 1,669 | 82.08M |
| 235 | MANE | Veradermics, Incorporated | 2.24B | 3.34% | 142,610 | - |
| 236 | MLYS | Mineralys Therapeutics, Inc. | 2.24B | -2.13% | 1,035,613 | - |
| 237 | NKTR | Nektar Therapeutics | 2.23B | 3.69% | 456,476 | 55.23M |
| 238 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.19% | 1,326,443 | 158.18M |
| 239 | NEOG | Neogen Corporation | 2.18B | -2.95% | 5,811,696 | 870.56M |
| 240 | SNDX | Syndax Pharmaceuticals, Inc. | 2.18B | 0.81% | 708,768 | 172.35M |
| 241 | DFTX | Definium Therapeutics, Inc. | 2.14B | 1.90% | 1,561,457 | - |
| 242 | AUPH | Aurinia Pharmaceuticals Inc. | 2.12B | 0.44% | 954,339 | 283.06M |
| 243 | STOK | Stoke Therapeutics, Inc. | 2.08B | 0.80% | 493,179 | 184.42M |
| 244 | ADPT | Adaptive Biotechnologies Corporation | 2.06B | -9.70% | 1,740,002 | 276.98M |
| 245 | SEM | Select Medical Holdings Corporation | 2.03B | 0.12% | 882,360 | 5.45B |
| 246 | OCUL | Ocular Therapeutix, Inc. | 2.02B | 10.45% | 5,116,575 | 51.95M |
| 247 | ZYME | Zymeworks Inc. | 2.02B | 2.40% | 396,731 | 105.97M |
| 248 | BHC | Bausch Health Companies Inc. | 2.00B | 0.75% | 897,886 | 10.27B |
| 249 | TYRA | Tyra Biosciences, Inc. | 1.98B | -1.19% | 1,005,783 | - |
| 250 | ANAB | AnaptysBio, Inc. | 1.97B | 4.58% | 373,402 | 234.60M |
| 251 | GRAL | GRAIL, Inc. | 1.95B | -6.34% | 908,685 | 147.17M |
| 252 | AHG | Akso Health Group | 1.94B | -1.31% | 150,387 | 14.84M |
| 253 | MESO | Mesoblast Limited | 1.93B | 4.53% | 344,855 | 65.38M |
| 254 | AGIO | Agios Pharmaceuticals, Inc. | 1.93B | -2.52% | 867,784 | 54.03M |
| 255 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.91B | 2.36% | 1,217,988 | -665.00K |
| 256 | GLPG | Galapagos NV | 1.88B | -1.14% | 112,168 | 1.31B |
| 257 | PVLA | Palvella Therapeutics, Inc. | 1.86B | 5.71% | 356,749 | - |
| 258 | ESTA | Establishment Labs Holdings Inc. | 1.82B | 0.08% | 462,448 | 211.08M |
| 259 | CAPR | Capricor Therapeutics, Inc. | 1.82B | 0.03% | 686,540 | 11.13M |
| 260 | OGN | Organon & Co. | 1.80B | 17.92% | 10,019,134 | 6.22B |
| 261 | INVA | Innoviva, Inc. | 1.79B | 2.46% | 657,771 | 411.33M |
| 262 | PHVS | Pharvaris N.V. | 1.77B | -1.78% | 105,956 | - |
| 263 | AORT | Artivion, Inc. | 1.77B | 1.25% | 327,912 | 441.33M |
| 264 | WGS | GeneDx Holdings Corp. | 1.76B | -8.45% | 1,005,396 | 427.54M |
| 265 | SION | Sionna Therapeutics, Inc. | 1.75B | 5.25% | 352,487 | - |
| 266 | RXRX | Recursion Pharmaceuticals, Inc. | 1.75B | -2.36% | 8,762,396 | 74.68M |
| 267 | MD | Pediatrix Medical Group, Inc. | 1.73B | -0.19% | 565,289 | 1.91B |
| 268 | AXGN | Axogen, Inc. | 1.71B | -2.88% | 1,140,107 | 225.21M |
| 269 | VCEL | Vericel Corporation | 1.71B | -1.29% | 347,984 | 276.26M |
| 270 | TRVI | Trevi Therapeutics, Inc. | 1.71B | 1.76% | 1,136,050 | - |
| 271 | HRMY | Harmony Biosciences Holdings, Inc. | 1.69B | 2.42% | 645,560 | 868.45M |
| 272 | ADUS | Addus HomeCare Corporation | 1.68B | 0.51% | 386,590 | 1.42B |
| 273 | NRIX | Nurix Therapeutics, Inc. | 1.68B | 4.10% | 1,191,089 | 71.78M |
| 274 | ATEC | Alphatec Holdings, Inc. | 1.68B | -5.06% | 2,369,723 | 764.16M |
| 275 | ANIP | ANI Pharmaceuticals, Inc. | 1.67B | 1.43% | 334,579 | 883.37M |
| 276 | AHCO | AdaptHealth Corp. | 1.66B | 0.33% | 968,643 | 3.24B |
| 277 | SGRY | Surgery Partners, Inc. | 1.66B | 2.29% | 813,075 | 3.31B |
| 278 | IOVA | Iovance Biotherapeutics, Inc. | 1.65B | 15.56% | 26,759,361 | 263.50M |
| 279 | RAPP | Rapport Therapeutics, Inc. | 1.64B | 1.57% | 198,250 | - |
| 280 | NTLA | Intellia Therapeutics, Inc. | 1.63B | -0.29% | 1,438,782 | 67.67M |
| 281 | INSP | Inspire Medical Systems, Inc. | 1.63B | 6.20% | 1,748,500 | 911.98M |
| 282 | OMCL | Omnicell, Inc. | 1.61B | -0.28% | 307,115 | 1.18B |
| 283 | IMCR | Immunocore Holdings plc | 1.61B | -0.13% | 289,050 | 400.02M |
| 284 | DMRA | Damora Therapeutics, Inc. | 1.61B | 4.26% | 337,203 | - |
| 285 | OCS | Oculis Holding AG | 1.61B | -0.55% | 104,233 | 1.51M |
| 286 | NUVB | Nuvation Bio Inc. | 1.59B | 2.21% | 1,973,609 | 62.90M |
| 287 | VRDN | Viridian Therapeutics, Inc. | 1.57B | 6.29% | 2,719,144 | 70.85M |
| 288 | VIR | Vir Biotechnology, Inc. | 1.57B | 3.26% | 2,107,618 | 68.56M |
| 289 | UFPT | UFP Technologies, Inc. | 1.57B | 1.55% | 167,828 | 602.80M |
| 290 | MBX | MBX Biosciences, Inc. | 1.56B | 3.79% | 467,322 | - |
| 291 | SNDA | Sonida Senior Living, Inc. | 1.52B | -0.55% | 532,215 | 336.39M |
| 292 | PGEN | Precigen, Inc. | 1.51B | 3.64% | 2,615,870 | 9.68M |
| 293 | ARDX | Ardelyx, Inc. | 1.50B | 0.49% | 2,582,294 | 407.32M |
| 294 | SVRA | Savara Inc. | 1.49B | -1.18% | 992,000 | - |
| 295 | GENB | Generate Biomedicines, Inc. | 1.47B | -3.43% | 205,382 | 31.89M |
| 296 | PRGO | Perrigo Company plc | 1.46B | -2.12% | 2,189,393 | 4.25B |
| 297 | NBTX | Nanobiotix S.A. | 1.46B | -0.71% | 62,677 | 38.27M |
| 298 | OLMA | Olema Pharmaceuticals, Inc. | 1.45B | 6.05% | 1,017,254 | - |
| 299 | GLUE | Monte Rosa Therapeutics, Inc. | 1.44B | 5.43% | 870,686 | 123.67M |
| 300 | BCAX | Bicara Therapeutics Inc. | 1.44B | 1.71% | 654,103 | - |
| 301 | AVAH | Aveanna Healthcare Holdings Inc. | 1.44B | -0.30% | 920,321 | 2.43B |
| 302 | IMTX | Immatics N.V. | 1.43B | 1.23% | 356,734 | 56.67M |
| 303 | ATRC | AtriCure, Inc. | 1.42B | -0.60% | 543,361 | 534.53M |
| 304 | BHVN | Biohaven Ltd. | 1.41B | 0.11% | 1,393,243 | - |
| 305 | ASTH | Astrana Health, Inc. | 1.40B | 2.99% | 300,600 | 3.18B |
| 306 | MLTX | MoonLake Immunotherapeutics | 1.39B | 4.35% | 1,695,848 | - |
| 307 | NVAX | Novavax, Inc. | 1.39B | 1.43% | 2,307,764 | 1.12B |
| 308 | HROW | Harrow, Inc. | 1.39B | 1.52% | 267,401 | 272.30M |
| 309 | MAZE | Maze Therapeutics, Inc. | 1.39B | -0.75% | 856,025 | 2.50M |
| 310 | ENOV | Enovis Corporation | 1.38B | 0.88% | 547,365 | 2.25B |
| 311 | ARDT | Ardent Health, Inc. | 1.36B | 2.14% | 275,331 | 6.32B |
| 312 | HCSG | Healthcare Services Group, Inc. | 1.36B | 0.68% | 531,189 | 1.84B |
| 313 | ATAI | AtaiBeckley Inc. | 1.35B | -1.60% | 2,061,771 | 4.09M |
| 314 | TNDM | Tandem Diabetes Care, Inc. | 1.35B | 1.71% | 982,468 | 1.01B |
| 315 | WVE | Wave Life Sciences Ltd. | 1.35B | 0.85% | 2,556,782 | 42.73M |
| 316 | TSHA | Taysha Gene Therapies, Inc. | 1.33B | 1.76% | 1,367,037 | 9.77M |
| 317 | CRVS | Corvus Pharmaceuticals, Inc. | 1.32B | 5.31% | 678,693 | - |
| 318 | PRCT | PROCEPT BioRobotics Corporation | 1.31B | -2.51% | 1,116,599 | 308.05M |
| 319 | PLSE | Pulse Biosciences, Inc. | 1.31B | 1.00% | 169,488 | 350.00K |
| 320 | PGNY | Progyny, Inc. | 1.29B | -2.36% | 1,192,156 | 1.29B |
| 321 | MPLT | MapLight Therapeutics, Inc. | 1.29B | 21.33% | 536,729 | - |
| 322 | ZBIO | Zenas BioPharma, Inc. | 1.27B | 2.01% | 554,273 | 10.00M |
| 323 | NVCR | NovoCure Limited | 1.25B | 1.95% | 977,582 | 655.35M |
| 324 | STAA | STAAR Surgical Company | 1.25B | 20.74% | 5,575,159 | 239.44M |
| 325 | IRMD | IRADIMED CORPORATION | 1.22B | -1.82% | 150,788 | 83.81M |
| 326 | AVBP | ArriVent BioPharma, Inc. | 1.20B | 7.92% | 1,333,795 | - |
| 327 | PHAR | Pharming Group N.V. | 1.20B | - | 1,391 | 376.13M |
| 328 | EYPT | EyePoint, Inc. | 1.19B | 0.42% | 903,901 | 31.37M |
| 329 | NNNN | Anbio Biotechnology | 1.18B | -0.33% | 48,295 | 8.65M |
| 330 | DBVT | DBV Technologies S.A. | 1.17B | -0.51% | 117,673 | 5.64M |
| 331 | USPH | U.S. Physical Therapy, Inc. | 1.16B | 0.35% | 179,839 | 773.34M |
| 332 | INNV | InnovAge Holding Corp. | 1.15B | 1.68% | 270,788 | 915.37M |
| 333 | GERN | Geron Corporation | 1.13B | 2.92% | 17,943,745 | 183.88M |
| 334 | ALVO | Alvotech | 1.13B | 0.56% | 436,101 | 588.90M |
| 335 | KMTS | Kestra Medical Technologies, Ltd. | 1.12B | -1.89% | 236,091 | 83.72M |
| 336 | COLL | Collegium Pharmaceutical, Inc. | 1.12B | 5.44% | 568,878 | 780.57M |
| 337 | SEPN | Septerna, Inc. | 1.12B | 1.39% | 220,936 | 45.95M |
| 338 | CNMD | CONMED Corporation | 1.11B | 0.93% | 388,587 | 1.37B |
| 339 | PNTG | The Pennant Group, Inc. | 1.11B | 2.13% | 115,674 | 947.71M |
| 340 | INBX | Inhibrx Biosciences, Inc. | 1.11B | 12.84% | 509,119 | 1.30M |
| 341 | BFLY | Butterfly Network, Inc. | 1.06B | 0.24% | 2,966,713 | 97.61M |
| 342 | AZTA | Azenta, Inc. | 1.04B | 1.61% | 777,163 | 595.03M |
| 343 | ABCL | AbCellera Biologics Inc. | 1.04B | 0.29% | 2,029,444 | 75.13M |
| 344 | ORIC | ORIC Pharmaceuticals, Inc. | 1.04B | 14.70% | 2,389,585 | - |
| 345 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | 1.52% | 1,604,292 | 291.85M |
| 346 | NEO | NeoGenomics, Inc. | 1.03B | -3.41% | 1,124,199 | 727.33M |
| 347 | EVMN | Evommune, Inc. | 1.03B | 5.60% | 285,768 | 13.00M |
| 348 | KALV | KalVista Pharmaceuticals, Inc. | 1.02B | 3.53% | 582,222 | 73.62M |
| 349 | QURE | uniQure N.V. | 1.02B | 2.58% | 1,051,581 | 16.10M |
| 350 | PHAT | Phathom Pharmaceuticals, Inc. | 1.00B | 7.03% | 1,676,075 | 175.11M |
| 351 | CLOV | Clover Health Investments, Corp. | 1.00B | -0.52% | 2,249,148 | 1.92B |
| 352 | URGN | UroGen Pharma Ltd. | 999.45M | 7.49% | 1,158,016 | 109.79M |
| 353 | BLFS | BioLife Solutions, Inc. | 989.18M | 3.91% | 415,598 | 96.21M |
| 354 | ANNX | Annexon, Inc. | 985.31M | 1.49% | 1,301,647 | - |
| 355 | CMPX | Compass Therapeutics, Inc. | 981.48M | 0.93% | 2,686,305 | 850.00K |
| 356 | IVA | Inventiva S.A. | 979.97M | 3.77% | 335,653 | 9.31M |
| 357 | AKTS | Aktis Oncology, Inc. | 976.73M | 4.06% | 292,399 | 6.50M |
| 358 | CRON | Cronos Group Inc. | 970.60M | 0.79% | 893,535 | 146.59M |
| 359 | PCRX | Pacira BioSciences, Inc. | 964.47M | 2.45% | 278,034 | 726.41M |
| 360 | QDEL | QuidelOrtho Corporation | 963.36M | -7.64% | 1,989,754 | 2.73B |
| 361 | GHRS | GH Research PLC | 947.19M | 1.87% | 51,323 | - |
| 362 | AMPH | Amphastar Pharmaceuticals, Inc. | 946.88M | 2.30% | 519,217 | 719.89M |
| 363 | EVO | Evotec SE | 938.89M | -2.60% | 31,947 | 925.65M |
| 364 | TDOC | Teladoc Health, Inc. | 936.58M | -0.38% | 5,482,248 | 2.53B |
| 365 | CGEM | Cullinan Therapeutics, Inc. | 920.60M | 1.67% | 551,064 | - |
| 366 | XNCR | Xencor, Inc. | 918.93M | 2.29% | 1,013,458 | 125.58M |
| 367 | CTMX | CytomX Therapeutics, Inc. | 916.59M | -0.24% | 3,958,167 | 76.20M |
| 368 | SLS | SELLAS Life Sciences Group, Inc. | 906.89M | 3.91% | 5,493,482 | - |
| 369 | SSII | SS Innovations International, Inc. | 903.73M | 5.12% | 20,421 | 42.48M |
| 370 | JBIO | Jade Biosciences, Inc. | 899.04M | 8.77% | 1,235,211 | - |
| 371 | LMRI | Lumexa Imaging Holdings, Inc. | 893.82M | -2.31% | 488,288 | 1.02B |
| 372 | OPK | OPKO Health, Inc. | 888.11M | -1.68% | 1,440,602 | 606.88M |
| 373 | JANX | Janux Therapeutics, Inc. | 883.88M | - | 627,740 | 10.00M |
| 374 | FTRE | Fortrea Holdings Inc. | 877.03M | -2.60% | 736,771 | 2.72B |
| 375 | INMD | InMode Ltd. | 867.38M | -0.65% | 765,144 | 370.50M |
| 376 | TALK | Talkspace, Inc. | 862.95M | 0.10% | 1,408,931 | 228.87M |
| 377 | OMER | Omeros Corporation | 857.47M | 3.48% | 1,279,647 | - |
| 378 | CDNA | CareDx, Inc. | 854.80M | -6.86% | 871,515 | 379.81M |
| 379 | TBPH | Theravance Biopharma, Inc. | 852.21M | -0.30% | 301,676 | 107.46M |
| 380 | SDGR | Schrödinger, Inc. | 846.77M | -0.26% | 1,625,086 | 255.87M |
| 381 | VOR | Vor Biopharma Inc. | 845.30M | -0.95% | 954,651 | - |
| 382 | DRUG | Bright Minds Biosciences Inc. | 841.67M | 3.81% | 241,796 | - |
| 383 | ABUS | Arbutus Biopharma Corporation | 840.56M | -1.83% | 1,870,908 | 14.08M |
| 384 | SANA | Sana Biotechnology, Inc. | 832.62M | -2.80% | 1,603,700 | - |
| 385 | CERT | Certara, Inc. | 829.49M | -0.37% | 4,463,778 | 418.84M |
| 386 | SPRY | ARS Pharmaceuticals, Inc. | 821.19M | 0.98% | 2,107,817 | 84.28M |
| 387 | MRVI | Maravai LifeSciences Holdings, Inc. | 799.48M | - | 1,460,728 | 185.74M |
| 388 | RLMD | Relmada Therapeutics, Inc. | 798.20M | 8.56% | 1,559,822 | - |
| 389 | SLDB | Solid Biosciences Inc. | 796.97M | 1.00% | 723,970 | - |
| 390 | BIOA | BioAge Labs, Inc. | 789.52M | -1.39% | 227,774 | 9.00M |
| 391 | MNKD | MannKind Corporation | 788.74M | -1.92% | 3,291,189 | 348.97M |
| 392 | KURA | Kura Oncology, Inc. | 781.72M | 0.68% | 764,470 | 67.48M |
| 393 | TLRY | Tilray Brands, Inc. | 781.05M | -0.44% | 2,374,666 | 858.28M |
| 394 | DSGN | Design Therapeutics, Inc. | 770.29M | -1.42% | 203,993 | - |
| 395 | IART | Integra LifeSciences Holdings Corporation | 766.12M | 2.18% | 626,629 | 1.64B |
| 396 | MGTX | MeiraGTx Holdings plc | 760.71M | -0.53% | 404,927 | 81.39M |
| 397 | BVS | Bioventus Inc. | 756.71M | -0.44% | 334,237 | 568.09M |
| 398 | TENX | Tenax Therapeutics, Inc. | 752.49M | -0.60% | 1,164,165 | - |
| 399 | LXRX | Lexicon Pharmaceuticals, Inc. | 745.68M | 5.39% | 3,947,866 | 49.80M |
| 400 | GDRX | GoodRx Holdings, Inc. | 739.96M | 0.93% | 871,705 | 796.85M |
| 401 | ETON | Eton Pharmaceuticals, Inc. | 739.41M | 2.65% | 333,142 | 79.95M |
| 402 | NUTX | Nutex Health Inc. | 736.55M | 0.63% | 164,805 | 875.26M |
| 403 | CMPS | COMPASS Pathways plc | 719.39M | -2.45% | 1,209,401 | - |
| 404 | ANRO | Alto Neuroscience, Inc. | 715.58M | 3.18% | 194,049 | - |
| 405 | AMN | AMN Healthcare Services, Inc. | 714.75M | -2.58% | 738,045 | 2.73B |
| 406 | ARVN | Arvinas, Inc. | 714.44M | -0.36% | 455,298 | 262.60M |
| 407 | EHAB | Enhabit, Inc. | 709.62M | - | 878,302 | 1.06B |
| 408 | ALLO | Allogene Therapeutics, Inc. | 709.39M | 7.78% | 4,859,324 | 22.00K |
| 409 | SGP | SpyGlass Pharma, Inc. | 709.31M | -4.50% | 62,362 | - |
| 410 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 708.69M | 2.49% | 353,929 | - |
| 411 | OMDA | Omada Health, Inc. | 705.93M | -4.39% | 553,648 | 260.21M |
| 412 | CBLL | CeriBell, Inc. | 699.00M | -0.59% | 248,500 | 89.06M |
| 413 | CSTL | Castle Biosciences, Inc. | 696.60M | -6.99% | 216,127 | 344.23M |
| 414 | LBRX | LB Pharmaceuticals Inc | 665.11M | 1.19% | 317,296 | - |
| 415 | GYRE | Gyre Therapeutics, Inc. | 661.11M | 2.12% | 34,198 | 116.59M |
| 416 | AVNS | Avanos Medical, Inc. | 655.29M | 1.22% | 373,520 | 701.20M |
| 417 | DRTS | Alpha Tau Medical Ltd. | 646.87M | 2.08% | 280,372 | - |
| 418 | PSNL | Personalis, Inc. | 637.49M | -3.79% | 1,656,815 | 69.65M |
| 419 | FBRX | Forte Biosciences, Inc. | 636.24M | 29.04% | 2,742,239 | - |
| 420 | CBIO | Crescent Biopharma, Inc. | 634.39M | 4.26% | 121,144 | 10.84M |
| 421 | OCGN | Ocugen, Inc. | 631.87M | 0.54% | 5,801,665 | 4.41M |
| 422 | PRME | Prime Medicine, Inc. | 621.55M | -0.85% | 1,369,598 | 4.63M |
| 423 | SIBN | SI-BONE, Inc. | 604.62M | -1.72% | 1,223,024 | 200.93M |
| 424 | MDXG | MiMedx Group, Inc. | 598.72M | 1.51% | 1,376,072 | 418.63M |
| 425 | CTKB | Cytek Biosciences, Inc. | 593.90M | -0.86% | 451,495 | 201.49M |
| 426 | IRWD | Ironwood Pharmaceuticals, Inc. | 587.01M | 2.56% | 1,050,945 | 296.15M |
| 427 | HSTM | HealthStream, Inc. | 584.48M | -2.07% | 216,333 | 304.06M |
| 428 | TECX | Tectonic Therapeutic, Inc. | 583.77M | 3.43% | 167,086 | - |
| 429 | CRMD | CorMedix Inc. | 581.81M | 1.80% | 723,308 | 311.71M |
| 430 | KYTX | Kyverna Therapeutics, Inc. | 579.16M | 3.90% | 690,351 | - |
| 431 | PROK | ProKidney Corp. | 573.64M | 2.70% | 538,503 | 893.00K |
| 432 | ZVRA | Zevra Therapeutics, Inc. | 570.09M | 1.25% | 671,551 | 106.47M |
| 433 | PRTA | Prothena Corporation plc | 569.55M | -0.66% | 414,711 | 9.68M |
| 434 | ACRS | Aclaris Therapeutics, Inc. | 567.10M | 3.29% | 1,064,183 | 7.83M |
| 435 | UPB | Upstream Bio, Inc. | 567.06M | 5.89% | 813,224 | 2.85M |
| 436 | RIGL | Rigel Pharmaceuticals, Inc. | 563.62M | 2.62% | 368,100 | 294.28M |
| 437 | ESPR | Esperion Therapeutics, Inc. | 559.85M | -6.44% | 8,228,873 | 403.14M |
| 438 | LYEL | Lyell Immunopharma, Inc. | 556.38M | 4.10% | 122,142 | 36.00K |
| 439 | BWAY | BrainsWay Ltd. | 553.94M | 8.09% | 247,965 | 52.23M |
| 440 | TCMD | Tactile Systems Technology, Inc. | 545.10M | -0.75% | 254,236 | 329.52M |
| 441 | VALN | Valneva SE | 534.59M | -1.60% | 15,968 | 205.07M |
| 442 | ZURA | Zura Bio Limited | 531.33M | -1.75% | 563,245 | - |
| 443 | STTK | Shattuck Labs, Inc. | 529.58M | 5.41% | 987,480 | 1.00M |
| 444 | LRMR | Larimar Therapeutics, Inc. | 528.76M | - | 1,401,886 | - |
| 445 | FULC | Fulcrum Therapeutics, Inc. | 526.81M | 0.13% | 600,696 | 80.00M |
| 446 | EMBC | Embecta Corp. | 525.28M | -0.11% | 682,997 | 1.08B |
| 447 | IMMX | Immix Biopharma, Inc. | 516.87M | 11.43% | 943,950 | - |
| 448 | AVR | Anteris Technologies Global Corp. | 516.34M | 1.29% | 555,830 | 1.91M |
| 449 | CATX | Perspective Therapeutics, Inc. | 511.56M | 2.75% | 594,671 | 884.00K |
| 450 | AQST | Aquestive Therapeutics, Inc. | 508.93M | -0.24% | 723,894 | 44.55M |
| 451 | TRDA | Entrada Therapeutics, Inc. | 505.80M | -1.89% | 144,538 | 25.42M |
| 452 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 453 | IVVD | Invivyd, Inc. | 503.39M | 31.85% | 12,983,338 | 53.43M |
| 454 | FDMT | 4D Molecular Therapeutics, Inc. | 502.35M | -2.57% | 389,098 | 85.21M |
| 455 | OFIX | Orthofix Medical Inc. | 498.59M | 1.80% | 233,752 | 822.31M |
| 456 | AGMB | AgomAb Therapeutics NV | 497.60M | 3.65% | 193,355 | - |
| 457 | NPCE | NeuroPace, Inc. | 493.22M | -1.01% | 114,144 | 99.99M |
| 458 | PHR | Phreesia, Inc. | 491.57M | -7.54% | 2,199,721 | 480.59M |
| 459 | VSTM | Verastem, Inc. | 491.00M | 2.57% | 1,618,287 | 30.91M |
| 460 | REPL | Replimune Group, Inc. | 488.00M | 0.34% | 8,356,468 | - |
| 461 | EIKN | Eikon Therapeutics, Inc. | 487.79M | -5.16% | 245,699 | - |
| 462 | ENGN | enGene Holdings Inc. | 487.01M | -0.55% | 186,018 | - |
| 463 | KMDA | Kamada Ltd. | 481.97M | 0.47% | 29,804 | 180.46M |
| 464 | CTNM | Contineum Therapeutics, Inc. | 479.02M | 0.31% | 123,168 | - |
| 465 | ADCT | ADC Therapeutics SA | 477.69M | 0.80% | 630,057 | 81.36M |
| 466 | LXEO | Lexeo Therapeutics, Inc. | 476.38M | -0.16% | 531,935 | - |
| 467 | ASMB | Assembly Biosciences, Inc. | 473.50M | 1.70% | 113,379 | 72.30M |
| 468 | AVIR | Atea Pharmaceuticals, Inc. | 465.28M | -1.52% | 252,026 | - |
| 469 | VTVT | vTv Therapeutics Inc. | 462.88M | -3.02% | 61,713 | 17.00K |
| 470 | RGNX | REGENXBIO Inc. | 462.49M | 3.34% | 470,975 | 170.44M |
| 471 | VREX | Varex Imaging Corporation | 459.44M | -0.72% | 209,031 | 854.40M |
| 472 | ABSI | Absci Corporation | 451.41M | -1.34% | 3,407,035 | 2.80M |
| 473 | STRO | Sutro Biopharma, Inc. | 443.34M | -1.07% | 186,808 | 102.48M |
| 474 | ANL | Adlai Nortye Ltd. | 442.80M | -0.25% | 718,294 | -1.35M |
| 475 | AUNA | Auna S.A. | 442.60M | 0.67% | 311,238 | 1.30B |
| 476 | ALT | Altimmune, Inc. | 439.76M | 0.30% | 1,989,238 | 41.00K |
| 477 | XOMA | XOMA Royalty Corporation | 438.02M | 6.06% | 307,972 | 52.15M |
| 478 | EBS | Emergent BioSolutions Inc. | 436.40M | 0.72% | 415,671 | 742.90M |
| 479 | AURA | Aura Biosciences, Inc. | 434.94M | 0.15% | 316,042 | - |
| 480 | EPRX | Eupraxia Pharmaceuticals Inc. | 433.75M | 2.91% | 129,663 | - |
| 481 | VNDA | Vanda Pharmaceuticals Inc. | 433.26M | 0.55% | 1,095,312 | 216.11M |
| 482 | FLGT | Fulgent Genetics, Inc. | 433.25M | -5.12% | 415,879 | 322.67M |
| 483 | BBNX | Beta Bionics, Inc. | 427.40M | -1.63% | 830,724 | 100.25M |
| 484 | ARMP | Armata Pharmaceuticals, Inc. | 422.38M | -4.87% | 35,315 | 4.90M |
| 485 | CYH | Community Health Systems, Inc. | 421.67M | 1.61% | 1,137,431 | 12.49B |
| 486 | ANGO | AngioDynamics, Inc. | 420.57M | -0.79% | 459,707 | 313.73M |
| 487 | MYGN | Myriad Genetics, Inc. | 415.18M | -6.92% | 1,415,367 | 824.50M |
| 488 | CGC | Canopy Growth Corporation | 413.19M | 4.81% | 16,183,412 | 203.04M |
| 489 | PACB | Pacific Biosciences of California, Inc. | 407.70M | -8.16% | 5,580,315 | 160.01M |
| 490 | YDES | YD Bio Limited | 406.45M | 0.35% | 17,232 | 510.36K |
| 491 | IPSC | Century Therapeutics, Inc. | 406.17M | -1.31% | 1,618,518 | 109.16M |
| 492 | ENTA | Enanta Pharmaceuticals, Inc. | 404.82M | 1.31% | 108,334 | 66.98M |
| 493 | KIDS | OrthoPediatrics Corp. | 402.94M | -0.44% | 105,556 | 236.35M |
| 494 | PBYI | Puma Biotechnology, Inc. | 396.84M | 3.86% | 338,306 | 228.37M |
| 495 | RCKT | Rocket Pharmaceuticals, Inc. | 392.84M | - | 2,397,022 | - |
| 496 | IRD | Opus Genetics, Inc. | 391.32M | 6.80% | 993,086 | 14.20M |
| 497 | AUTL | Autolus Therapeutics plc | 391.23M | -1.34% | 2,059,859 | 75.39M |
| 498 | NRC | National Research Corporation | 387.83M | -1.22% | 55,591 | 137.39M |
| 499 | MNPR | Monopar Therapeutics Inc. | 387.61M | -0.19% | 391,629 | - |
| 500 | PRTC | PureTech Health plc | 387.51M | 4.65% | 1,717 | 6.39M |